BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3504058)

  • 1. 7 alpha-substituted androstenediones as effective in vitro and in vivo inhibitors of aromatase.
    Brueggemeier RW; Li PK; Snider CE; Darby MV; Katlic NE
    Steroids; 1987; 50(1-3):163-78. PubMed ID: 3504058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione in MCF-7 human mammary carcinoma cell culture.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1987 Sep; 47(17):4548-51. PubMed ID: 3621153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the aromatase inhibitor 7 alpha-(4'-amino)phenylthio-4-androstene-3,17-dione on 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats.
    Brueggemeier RW; Li PK
    Cancer Res; 1988 Dec; 48(23):6808-10. PubMed ID: 3141048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemistry and pharmacology of 7alpha-substituted androstenediones as aromatase inhibitors.
    Brueggemeier RW; O'Reilly JM; Lovely CJ; Ward PJ; Quinn AL; Baker D; Darby MV; Gu XJ; Gilbert NE
    J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):247-54. PubMed ID: 9365197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and pharmacological development of steroidal inhibitors of aromatase.
    Brueggemeier RW; Li PK; Chen HH; Moh PP; Katlic NE
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):379-85. PubMed ID: 2257241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
    Li PK; Brueggemeier RW
    J Med Chem; 1990 Jan; 33(1):101-5. PubMed ID: 2296006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aromatase inhibition by an enzyme-activated irreversible inhibitor in human carcinoma cell cultures.
    Brueggemeier RW; Katlic NE
    Cancer Res; 1990 Jun; 50(12):3652-6. PubMed ID: 2340513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    Ebrahimian S; Chen HH; Brueggemeier RW
    Steroids; 1993 Sep; 58(9):414-22. PubMed ID: 8236327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent enzyme-activated inhibition of aromatase by a 7 alpha-substituted C19 steroid.
    Snider CE; Brueggemeier RW
    J Biol Chem; 1987 Jun; 262(18):8685-9. PubMed ID: 3597393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW; Katlic NE; Kenreigh CA; Li PK
    J Steroid Biochem Mol Biol; 1992 Jan; 41(1):85-90. PubMed ID: 1734938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-Aminoandrostenedione derivatives: a novel class of irreversible aromatase inhibitors. Comparison with FCE 24304 and 4-hydroxyandrostenedione.
    Di Salle E; Giudici D; Ornati G; Briatico G; D'Alessio R; Villa V; Lombardi P
    J Steroid Biochem Mol Biol; 1990 Nov; 37(3):369-74. PubMed ID: 2257240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of 4-substituted-4-androstene-3,17-dione derivatives as aromatase inhibitors.
    Abul-Hajj YJ; Liu XP; Hedge M
    J Steroid Biochem Mol Biol; 1995 Aug; 54(3-4):111-9. PubMed ID: 7662584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substituted C19 steroid analogs as inhibitors of aromatase.
    Brueggemeier RW; Snider CE; Counsell RE
    Cancer Res; 1982 Aug; 42(8 Suppl):3334s-3337s. PubMed ID: 7083196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
    Snider CE; Brueggemeier RW
    J Steroid Biochem; 1985 Mar; 22(3):325-30. PubMed ID: 3990283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biochemistry of fluorescent aromatase inhibitors.
    Chen HH; Brueggemeier RW
    Steroids; 1990 Mar; 55(3):123-7. PubMed ID: 2333659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the aromatase inhibitor, 4-(phenylthio)-4-androstene-3,17-dione, on dimethylbenz(A)anthracene-induced rat mammary tumors.
    Abul-Hajj YJ
    J Steroid Biochem; 1989; 34(1-6):439-42. PubMed ID: 2516585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of analogues of 4-androstene-3,17-dione as aromatase inhibitors.
    Rowlands MG; Foster AB; Mann J; Pietrzak B; Wilkinson J; Coombes RC
    Steroids; 1987; 49(4-5):371-82. PubMed ID: 3455049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a new series of mechanism-based aromatase inhibitors.
    Lesuisse D; Gourvest JF; Hartmann C; Tric B; Benslimane O; Philibert D; Vevert JP
    J Med Chem; 1992 May; 35(9):1588-97. PubMed ID: 1578485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exemestane (FCE 24304), a new steroidal aromatase inhibitor.
    di Salle E; Ornati G; Giudici D; Lassus M; Evans TR; Coombes RC
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):137-43. PubMed ID: 1525055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure elucidation, and biochemical evaluation of 7 alpha- and 7 beta-arylaliphatic-substituted androst-4-ene-3,17-diones as inhibitors of aromatase.
    O'Reilly JM; Li N; Duax WL; Brueggemeier RW
    J Med Chem; 1995 Jul; 38(15):2842-50. PubMed ID: 7636845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.